🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: ISHLT and AASLD guidelines recommend SARS-CoV2 vaccination in a...
Status
Completed
Location
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
Start Date
2021-10-01
Trial ID
NCT05116748
Treatments Being Tested
The primary aim of this innovative immunotherapeutic study is to determine ...
Status
Active Not Recruiting
Location
ZNA Cadix
Start Date
2012-10
Trial ID
NCT01686334
Treatments Being Tested
The risk of severe course of SARS-CoV-2 infection in people with Down Syndr...
Status
Unknown
Location
UMC utrecht
Start Date
2021-02-03
Trial ID
NCT05145348
The goal of this study is to assess serious adverse events associated with ...
Status
Completed
Location
CMIC Co., Ltd
Start Date
2022-11-15
Trial ID
NCT05894590
Immunocompromised individuals, such as solid organ transplant (SOT) recipie...
Status
Active Not Recruiting
Location
University of California, Davis
Start Date
2021-09-24
Trial ID
NCT05060991
Treatments Being Tested
The goal of this clinical trial is to compare different Coronavirus Disease...
Status
Completed
Location
Centre for the Evaluation of Vaccination (CEV)
Start Date
2021-05-26
Trial ID
NCT06189040
Treatments Being Tested
This study will collect information on the safety of BNT162b2 products for ...
Status
Active Not Recruiting
Location
Pfizer
Start Date
2022-03-18
Trial ID
NCT05032976
Treatments Being Tested
A Phase 1 study to evaluate safety, tolerability, and immunogenicity of SAR...
Status
Unknown
Location
Dr. Cipto Mangunkusumo Hospital
Start Date
2022-07-08
Trial ID
NCT05434585
Treatments Being Tested
This will be a randomized single-blind controlled trial to determine the im...
Status
Completed
Location
Hospital Ampang
Start Date
2022-09-20
Trial ID
NCT05517642
The purpose of this study is to evaluate the immunogenicity, safety, and re...
Status
Completed
Location
Pinnacle Research Group-409 E 10th St
Start Date
2023-10-19
Trial ID
NCT06097273
Treatments Being Tested